Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 17;11(1):27.
doi: 10.1186/s40981-025-00789-6.

Comprehensive evaluation of coagulability using thromboelastography in four patients with essential thrombocythemia

Shuji Kawamoto  1 , Tsuguhiro Matsumoto  2 , Yohei Chiwata  2 , Chikashi Takeda  2 , Eriko Kusudo  2 , Moritoki Egi  2
Affiliations

Comprehensive evaluation of coagulability using thromboelastography in four patients with essential thrombocythemia

Shuji Kawamoto et al. JA Clin Rep. .

Abstract

Background: Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by increased platelet count and risk of thrombosis and bleeding, which necessitates careful perioperative management. However, there are no standardized guidelines for perioperative antithrombotic therapy, and optimal preoperative evaluation remains unclear. In this report, we evaluate the utility of thromboelastography (TEG®6 s) for assessing coagulation and platelet function in ET patients undergoing surgery.

Case presentation: Four ET patients (platelet counts: 289,000-833,000/µL) underwent thromboelastography at anesthesia induction. Two had normal coagulation, while two had a hypercoagulable state undetected by conventional tests. Hypercoagulability was observed in patients who discontinued anticoagulants or antiplatelets preoperatively.

Conclusions: Thromboelastography identified thrombotic tendencies not evident with conventional coagulation tests, suggesting its potential for perioperative risk assessment in ET patients. This approach may improve individualized coagulation management beyond use of platelet counts and standard tests. Further studies are needed to establish the role of thromboelastography in optimizing perioperative antithrombotic strategies.

Keywords: Coagulation; Essential thrombocythemia; Platelet; Thromboelastography.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This work was conducted in the Department of Anesthesia, Kyoto University Hospital, with the approval of the Ethics Committee of Kyoto University Hospital (No. R4875). The work was carried out according to the guidelines of the Declaration of Helsinki. Consent for publication: Written consent was obtained from all the patients for publication of this case series. Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
TEG®6 s Global Hemostasis and PlateletMapping® results. A. Case 1, B. Case 2, C. Case 3, D. Case 4. Highlighted areas indicate abnormal values. The normal range of each parameter is shown at the bottom of the values. CK: citrate kaolin, CRT: citrated rapid TEG, CKH: citrate kaolin with heparinase, CFF: citrated functional fibrinogen, ActF: activator F, HKH: heparinized kaolin with heparinase, ADP: adenosine diphosphate. Shortened reaction time (R) and clot formation time (K), along with increased alpha angle (angle) and maximum amplitude (MA), are indicative of a hypercoagulable state. In this figure, Cases 2 and 3 show such hypercoagulable profiles, whereas Cases 1 and 4 exhibit values within the normal range, suggesting balanced coagulation
See this image and copyright information in PMC

References

    1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405. - DOI - PubMed
    1. Ruggeri M, Finazzi G, Tosetto A, Riva S, Rodeghiero F, Barbui T. No treatment for low-risk thrombocythaemia: results from a prospective study. Br J Haematol. 1998;103:772–7. - DOI - PubMed
    1. Barbui T, Vannucchi AM, Buxhofer-Ausch V, De Stefano V, Betti S, Rambaldi A, et al. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer J. 2015;5: e369. - DOI - PMC - PubMed
    1. Mital A, Prejzner W, Bieniaszewska M, Hellmann A. Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients. Pol Arch Med Wewn. 2015;125:914–20. - DOI - PubMed
    1. Varela C, Nassr M, Razak A, Yang SY, Kim NK. Postoperative bleeding in essential thrombocytosis patients with colorectal cancer: Case report and literature review. Int J Surg Case Rep. 2021;86: 106374. - DOI - PMC - PubMed